Author

V. Rosato

Second University of Naples - Cited by 1,290 - hepatology - internal medicine

Biography

Dr. Valerio Rosato is from Internal Medicine and Hepatology Department from University of Campania “L. Vanvitelli” which is located at Naples, Italy. His areas of research specializations are hepatology, internal medicine, Viral Infection, Liver Diseases, Cirrhosis, Infection, Hepatitis, Hepatocellular Carcinoma, Hepatitis B, Liver Cirrhosis, Liver Failure, Liver Diseases and Immunology. He published 42 articles in many journals and the articles are informative and got good citations.
Title
Cited by
Year
Role of oxidative stress in pathophysiology of nonalcoholic fatty liver disease
M Masarone, V Rosato, M Dallio, AG Gravina, A Aglitti, C Loguercio, ...Oxidative medicine and cellular longevity 2018, 2018201
504
2018
NAFLD and extra-hepatic comorbidities: current evidence on a multi-organ metabolic syndrome
V Rosato, M Masarone, M Dallio, A Federico, A Aglitti, M PersicoInternational journal of environmental research and public health 16 (18), 3415, 2019201
103
2019
Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damage
M Masarone, V Rosato, A Aglitti, T Bucci, R Caruso, T Salvatore, ...PloS one 12 (6), e0178473, 2017201
88
2017
Epidemiology and natural history of alcoholic liver disease
M Masarone, V Rosato, M Dallio, L Abenavoli, A Federico, C Loguercio, ...Reviews on recent clinical trials 11 (3), 167-174, 2016201
63
2016
Non alcoholic fatty liver disease and eNOS dysfunction in humans
M Persico, M Masarone, A Damato, M Ambrosio, A Federico, V Rosato, ...BMC gastroenterology 17, 1-9, 2017201
57
2017
Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis
L Rinaldi, F Nascimbeni, M Giordano, C Masetti, B Guerrera, A Amelia, ...World Journal of Gastroenterology 23 (8), 1458, 2017201
51
2017
Sustained virological response by direct antiviral agents in HCV leads to an early and significant improvement of liver fibrosis
M Persico, V Rosato, A Aglitti, D Precone, M Corrado, AD Luna, F Morisco, ...Antiviral Therapy 23 (2), 129-138, 2018201
45
2018
The role of fructose in non-alcoholic steatohepatitis: Old relationship and new insights
A Federico, V Rosato, M Masarone, P Torre, M Dallio, M Romeo, ...Nutrients 13 (4), 1314, 2021202
41
2021
Pharmacotherapy of alcoholic liver disease in clinical practice
V Rosato, L Abenavoli, A Federico, M Masarone, M PersicoInternational Journal of Clinical Practice 70 (2), 119-131, 2016201
38
2016
Real‐life glecaprevir/pibrentasvir in a large cohort of patients with hepatitis C virus infection: The MISTRAL study
M Persico, A Aglitti, M Milella, C Coppola, V Messina, E Claar, I Gentile, ...Liver International 39 (10), 1852-1859, 2019201
35
2019
Vascular endothelial dysfunction in inflammatory bowel diseases: pharmacological and nonpharmacological targets
AG Gravina, M Dallio, M Masarone, V Rosato, A Aglitti, M Persico, ...Oxidative medicine and cellular longevity 2018, 2018201
33
2018
Hepatocellular carcinoma in HCV cirrhosis after viral clearance with direct acting antiviral therapy: preliminary evidence and possible meanings
L Rinaldi, R Di Francia, N Coppola, B Guerrera, M Imparato, C Monari, ...Wcrj 3 (3), e748, 2016201
32
2016
Alcoholic hepatitis: pathogenesis, diagnosis and treatment
L Abenavoli, M Masarone, A Federico, V Rosato, M Dallio, C Loguercio, ...Reviews on recent clinical trials 11 (3), 159-166, 2016201
32
2016
Influence of antiviral therapy on the liver stiffness in chronic HBV hepatitis
L Rinaldi, A Ascione, V Messina, V Rosato, G Valente, V Sangiovanni, ...Infection 46, 231-238, 2018201
14
2018
Rapid virological response represents the highest prediction factor of response to antiviral treatment in HCV-related chronic hepatitis: a multicenter retrospective study
A Federico, M Masarone, M Romano, M Dallio, V Rosato, M PersicoHepatitis Monthly 15 (6), 2015201
13
2015
Pressure support ventilation vs continuous positive airway pressure for treating of acute cardiogenic pulmonary edema: a pilot study
A Pagano, FG Numis, V Rosato, T Russo, G Porta, G Bosso, C Serra, ...Respiratory Physiology & Neurobiology 255, 7-10, 2018201
13
2018
Impact of telaprevir in HCV patients with cirrhosis and RVR: real-life data from Boceprevir or Telaprevir based “triple therapy” experience in southern Italy
F Morisco, M Masarone, V Rosato, S Camera, R Granata, M T Tartaglione, ...Reviews on Recent Clinical Trials 11 (4), 306-316, 2016201
8
2016
Elimination of hepatitis C in Southern Italy: a model of HCV screening and linkage to care among hospitalized patients at different hospital divisions
V Rosato, LA Kondili, R Nevola, P Perillo, D Mastrocinque, A Aghemo, ...Viruses 14 (5), 1096, 2022202
7
2022
Factors affecting long‐term changes of liver stiffness in direct‐acting anti‐hepatitis C virus therapy: A multicentre prospective study
V Rosato, A Ascione, R Nevola, AL Fracanzani, G Piai, V Messina, ...Journal of Viral Hepatitis 29 (1), 26-34, 2022202
7
2022
Directly acting antiviral-based treatment for HCV-infected persons who inject drugs: A multicenter real-life study
V Messina, L Onorato, G Di Caprio, E Claar, V Iovinella, A Russo, ...Life 11 (1), 1, 2020202
7
2020

Referred From: https://scholar.google.com/citations?user=6KmQ-OQAAAAJ&hl=en&oi=sra

Cited by
Citations 1290
h-index 14
i10-index 18
Recommended Journals
Open Access Journals